For $50M, Water Street gets majority stake in Alpine Biomed
Alpine Biomed, a Fountain Valley, Calif., maker of diagnostic devices, sold a majority stake to the private-equity firm Water Street Healthcare Partners for $50 million, the Chicago Tribune reports. Alpine then used the cash infusion to purchase the neurodiagnostic arm of Medtronic.
The company’s release is here.
Next Story: Care.com, one-stop shop for child, pet, and elderly care
Previous Story: Tobira Therapeutics raises $31M to combat HIV
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
